Trending

EFPIA

EFPIA: Partnership is the key to healthcare’s biggest challenges

EFPIA: Partnership is the key to healthcare’s biggest challenges

The European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning

X

EFPIA: Partnership is the key to healthcare’s biggest challenges

https://pharmaphorum.com/sales-marketing/efpia-pharma-healthcare-partnership-guide/

Limited access to cancer biomarker testing in Europe, report finds

Limited access to cancer biomarker testing in Europe, report finds

There is limited access to biomarker testing for cancer in Europe, despite the huge potential of the technology

X

Limited access to cancer biomarker testing in Europe, report finds

https://pharmaphorum.com/news/limited-access-to-biomarker-testing-in-europe-report-finds/

UK parliament backs EU trade deal, as industry sifts through detail

UK parliament backs EU trade deal, as industry sifts through detail

The post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some

X

UK parliament backs EU trade deal, as industry sifts through detail

https://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/

Survey shows patients wait six times longer than EU neighbours for new drugs

Survey shows patients wait six times longer than EU neighbours for new drugs

Patients in some European countries are waiting up to six times longer for access to medicines than their neighbours,

X

Survey shows patients wait six times longer than EU neighbours for new drugs

https://pharmaphorum.com/news/survey-shows-patients-wait-six-times-longer-than-eu-neighbours-for-new-drugs/

#WeWontRest: The benefits of giving pharma a face

#WeWontRest: The benefits of giving pharma a face

The European pharmaceutical industry isn’t a faceless entity, it’s a community of more than 100,000 people all working

X

#WeWontRest: The benefits of giving pharma a face

https://pharmaphorum.com/patients/wewontrest-the-benefits-of-giving-pharma-a-face/

Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal

Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal

The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.

X

Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal

https://pharmaphorum.com/news/despite-no-pick-and-mix-warning-pharmas-brexit-planners-still-hope-for-deal/

Is Europe ready for a single health technology assessment?

Is Europe ready for a single health technology assessment?

The EU has unveiled plans for greater Health Technology Assessment harmonisation this week – and put the potential benefits for life sciences centre stage.

X

Is Europe ready for a single health technology assessment?

https://pharmaphorum.com/views-and-analysis/europe-hta-harmonisation/

European pharma: why #WeWontRest in developing breakthrough medicines

European pharma: why #WeWontRest in developing breakthrough medicines

Andrew Powrie-Smith from EFPIA talks about the European pharmaceutical industry organisation’s new #WeWontRest campaign, which highlights the sector’s

X

European pharma: why #WeWontRest in developing breakthrough medicines

https://pharmaphorum.com/views-and-analysis/european-pharma-wewontrest-developing-breakthrough-medicines/

Huge scale of Brexit threat to Europe’s medicines supplies revealed

Huge scale of Brexit threat to Europe’s medicines supplies revealed

New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.

X

Huge scale of Brexit threat to Europe’s medicines supplies revealed

https://pharmaphorum.com/views-and-analysis/huge-scale-brexit-threat-europes-medicines-supplies-revealed/

1 2 3

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com